DekaBank Deutsche Girozentrale Has $516,000 Position in Universal Health Services, Inc. (NYSE:UHS)

DekaBank Deutsche Girozentrale boosted its stake in shares of Universal Health Services, Inc. (NYSE:UHS) by 7.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,383 shares of the health services provider’s stock after acquiring an additional 228 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Universal Health Services were worth $516,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of UHS. UBS Group AG increased its stake in shares of Universal Health Services by 51.2% in the third quarter. UBS Group AG now owns 62,949 shares of the health services provider’s stock valued at $7,915,000 after buying an additional 21,325 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of Universal Health Services by 3.5% in the third quarter. JPMorgan Chase & Co. now owns 1,090,010 shares of the health services provider’s stock valued at $137,047,000 after buying an additional 37,243 shares in the last quarter. Lazard Asset Management LLC increased its stake in shares of Universal Health Services by 4,622.3% in the third quarter. Lazard Asset Management LLC now owns 16,906 shares of the health services provider’s stock valued at $2,125,000 after buying an additional 16,548 shares in the last quarter. Assenagon Asset Management S.A. increased its stake in shares of Universal Health Services by 16.7% in the fourth quarter. Assenagon Asset Management S.A. now owns 53,239 shares of the health services provider’s stock valued at $8,116,000 after buying an additional 7,616 shares in the last quarter. Finally, Aigen Investment Management LP acquired a new stake in shares of Universal Health Services in the third quarter valued at $466,000. 86.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

UHS has been the subject of a number of research reports. StockNews.com upgraded Universal Health Services from a “hold” rating to a “buy” rating in a research note on Monday, January 8th. Barclays initiated coverage on Universal Health Services in a research report on Wednesday, March 6th. They issued an “equal weight” rating and a $181.00 price objective for the company. UBS Group lifted their price objective on Universal Health Services from $152.00 to $177.00 and gave the stock a “neutral” rating in a research report on Thursday, February 29th. The Goldman Sachs Group lifted their price objective on Universal Health Services from $170.00 to $189.00 and gave the stock a “buy” rating in a research report on Monday, March 4th. Finally, JPMorgan Chase & Co. lifted their price objective on Universal Health Services from $144.00 to $182.00 and gave the stock a “neutral” rating in a research report on Wednesday, March 13th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $179.71.

Universal Health Services Trading Down 0.3 %

NYSE:UHS opened at $166.35 on Tuesday. Universal Health Services, Inc. has a fifty-two week low of $119.90 and a fifty-two week high of $183.61. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.40 and a quick ratio of 1.29. The stock has a market capitalization of $11.18 billion, a PE ratio of 16.21, a price-to-earnings-growth ratio of 0.80 and a beta of 1.24. The business’s 50-day simple moving average is $170.73 and its 200-day simple moving average is $151.47.

Universal Health Services (NYSE:UHS) last released its quarterly earnings data on Tuesday, February 27th. The health services provider reported $3.13 earnings per share for the quarter, beating the consensus estimate of $3.02 by $0.11. Universal Health Services had a return on equity of 12.08% and a net margin of 5.03%. The business had revenue of $3.70 billion for the quarter, compared to analysts’ expectations of $3.66 billion. During the same quarter in the previous year, the business posted $3.02 EPS. Universal Health Services’s revenue for the quarter was up 7.4% on a year-over-year basis. Sell-side analysts expect that Universal Health Services, Inc. will post 13.39 earnings per share for the current fiscal year.

Universal Health Services Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Friday, March 1st were issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 0.48%. The ex-dividend date was Thursday, February 29th. Universal Health Services’s dividend payout ratio (DPR) is presently 7.80%.

Insider Activity

In other Universal Health Services news, CFO Steve Filton sold 35,000 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $176.82, for a total value of $6,188,700.00. Following the sale, the chief financial officer now owns 68,785 shares in the company, valued at approximately $12,162,563.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 16.10% of the stock is currently owned by company insiders.

Universal Health Services Company Profile

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.